Table of Contents
Chapter 1 Report Scope
1.1 Segment Market Scope
1.2 Regional Scope
1.3 Estimates & Forecast Timeline
Chapter 2 Research Methodology
2.1 Model Details
2.1.1 Regression and variable analysis
2.2 Information Procurement
2.3 List Of Primary Sources
2.3.1 Purchased database:
2.3.2 GVR’s internal database
2.4 Primary Interview Breakup
2.4.1 Data for primary interviews, by sources
2.4.2 Data for primary interviews, by region
2.5 List Of Secondary Sources
Chapter 3 Report Objectives
3.1 Objectives
Chapter 4 Executive Summary
4.1 Market Summary
Chapter 5 Market Definitions
5.1 Definitions
Chapter 6 Neuroendocrine tumor treatment market: Industry Outlook
6.1 Market Variable Analysis
6.2 Market Driver Analysis
6.2.1 Increasing prevalence of neuroendocrine carcinoma
6.2.2 Technological advancements
6.2.3 Ongoing clinical
6.2.4 Rising number of government initiatives
6.3 Market Restraints Analysis
6.3.1 High cost of development
6.3.2 Lack of awareness among people
6.4 Business Environment Analysis Tools
6.4.1 Neuroendocrine tumor treatment market - SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
6.4.2 Porter’s Five Forces Analysis
Chapter 7 Regulatory & Political Forces
7.1 Regulatory Landscape
7.1.1 List of regulations, by country
7.1.2 U.S.
7.1.3 Canada
7.1.4 Europe
7.1.5 China
7.1.6 India
7.1.7 Mexico
7.1.8 Brazil
7.1.9 South Africa
7.2 Political Landscape, Current & Future Scenario
Chapter 8 Competitive & Vendor Landscape
8.1 Market Participation Categorization
8.1.1 Market leader
8.1.2 Innovators
8.2 Strategic Initiatives & Outcome Analysis
8.3 List of Key Companies, By Product
8.4 Company Market Share Analysis
8.4.1 Neuroendocrine tumor treatment market company market share analysis, 2017
Chapter 9 Neuroendocrine Tumor Treatment Market: Product Analysis
9.1 Product Business Analysis
9.2 Somatostatin Analogs (SSA)
9.2.1 Somatostatin analogs (SSA) estimates and forecasts, 2014 - 2025 (USD Million)
9.3 Targeted Therapy
9.3.1 Targeted therapy market estimates and forecasts, 2014 - 2025 (USD Million)
9.4 Others
9.4.1 other market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 10 Neuroendocrine Tumor Treatment Market: Site Analysis
10.1 Site Business Analysis
10.2 Lungs
10.2.1 Lungs estimates and forecasts, 2014 - 2025 (USD Million)
10.3 Pancreas
10.3.1 pancreas market estimates and forecasts, 2014 - 2025 (USD Million)
10.4 Colon
10.4.1 colon market estimates and forecasts, 2014 - 2025 (USD Million)
10.5 Small Intestine
10.5.1 small intestine market estimates and forecasts, 2014 - 2025 (USD Million)
10.6 Others
10.6.1 Others market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 11 Neuroendocrine tumor treatment market: End-use Analysis
11.1 End-use Business Analysis
11.2 Hospitals
11.2.1 hospitals estimates and forecasts, 2014 - 2025 (USD Million)
11.3 Clinics
11.3.1 clinics market estimates and forecasts, 2014 - 2025 (USD Million)
11.4 Others
11.4.1 other market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 12 Neuroendocrine tumor treatment market: Regional Analysis
12.1 North America
12.1.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.1.2 U.S.
12.1.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.1.3 Canada
12.1.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2 Europe
12.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.2 Germany
12.2.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.2.3 U.K.
12.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3 Asia Pacific
12.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3.2 China
12.3.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3.3 India
12.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.3.4 Japan
12.3.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4 Latin America
12.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4.2 Mexico
12.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.4.3 Brazil
12.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.5 MEA
12.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
12.5.2 South Africa
12.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 13 Company Profiles
13.1 Key Company Profiles
13.1.1 Novartis AG
13.1.1.1 Company overview
13.1.1.2 Financial performance
13.1.1.3 Product benchmarking
13.1.1.4 Strategic initiatives
13.1.2 Boehringer Ingelheim International GmbH
13.1.2.1 Company overview
13.1.2.2 Financial performance
13.1.2.3 Product benchmarking
13.1.2.4 Strategic initiatives
13.1.3 Dauntless Pharmaceuticals
13.1.3.1 Company overview
13.1.3.2 Product benchmarking
13.1.3.3 Strategic initiatives
13.1.4 Hutchison MediPharma Limited
13.1.4.1 Company overview
13.1.4.2 Product benchmarking
13.1.4.3 Strategic initiatives
13.1.5 AVEO Oncology
13.1.5.1 Company overview
13.1.5.2 Financial Performance
13.1.5.3 Product benchmarking
13.1.5.4 Strategic initiatives
13.1.6 Pfizer Inc.
13.1.6.1 Company overview
13.1.6.2 Financial performance
13.1.6.3 Product benchmarking
13.1.6.4 Strategic initiatives
13.1.7 Ipsen Pharma
13.1.7.1 Company overview
13.1.7.2 Product benchmarking
13.1.7.3 Strategic initiatives
13.1.8 Progenics Pharmaceuticals, Inc.
13.1.8.1 Company overview
13.1.8.2 Financial performance
13.1.8.3 Product benchmarking
13.1.8.4 Strategic initiatives
13.1.9 Tarveda Therapeutics
13.1.9.1 Company overview
13.1.9.2 Product benchmarking
13.1.9.3 Strategic initiatives
13.1.10 Exelixis, Inc.
13.1.10.1 Company overview
13.1.10.2 Financial performance
13.1.10.3 Product benchmarking
13.1.10.4 Strategic initiatives
Chapter 14 Recommendations/Conclusion
14.1 Recommendations
14.2 Conclusion
List of Tables
Table 1 Country share estimation
Table 2 List of regulations, by country
Table 3 List of key companies, by product
Table 4 North America neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 5 North America neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 6 North America neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 7 U.S. neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 8 U.S. neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 9 U.S. neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 10 Canada neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 11 Canada neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 12 Canada neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 13 Europe neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 14 Europe neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 15 Europe neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 16 Germany neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 17 Germany neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 18 Germany neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 19 U.K. neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 20 U.K. neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 21 U.K. neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 22 Asia Pacific neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 23 Asia Pacific neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 24 Asia Pacific neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 25 China neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 26 China neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 27 China neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 28 India neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 29 India neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 30 India neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 31 Latin America neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 32 Latin America neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 33 Latin America neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 34 Mexico neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 35 Mexico neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 36 Mexico neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 37 Brazil neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 38 Brazil neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 39 Brazil neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 40 MEA neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 41 MEA neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 42 MEA neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
Table 43 South Africa neuroendocrine tumor treatment market, by product, 2014 - 2025 (USD Million)
Table 44 South Africa neuroendocrine tumor treatment market, by site, 2014 - 2025 (USD Million)
Table 45 South Africa neuroendocrine tumor treatment market, by end-use, 2014 - 2025 (USD Million)
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Value chain - based sizing & forecasting
Fig. 4 QFD modeling for market share assessment
Fig. 5 Components: TAM
Fig. 6 Information procurement
Fig. 7 Primary interviews, by sources
Fig. 8 Primary interviews, by region
Fig. 9 Neuroendocrine tumor treatment market revenues, 2017, (USD Millions)
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Neuroendocrine tumor treatment market - SWOT analysis, by the factor (political & legal, economic and technological)
Fig. 14 Porter’s five forces analysis
Fig. 15 Market participant categorization
Fig. 16 Strategy framework analysis, 2017
Fig. 17 Neuroendocrine tumor treatment market share, 2017
Fig. 18 Neuroendocrine tumor treatment market product outlook: Key takeaways
Fig. 19 Neuroendocrine tumor treatment market: Product movement analysis
Fig. 20 Global somatostatin analog market, 2014 - 2025 (USD Million)
Fig. 21 Global targeted therapy market, 2014 - 2025 (USD Million)
Fig. 22 Global another market, 2014 - 2025 (USD Million)
Fig. 23 Neuroendocrine tumor treatment market site outlook: Key takeaways
Fig. 24 Neuroendocrine tumor treatment market: Site movement analysis
Fig. 25 Global lungs market, 2014 - 2025 (USD Million)
Fig. 26 Global pancreas market, 2014 - 2025 (USD Million)
Fig. 27 Global colon market, 2014 - 2025 (USD Million)
Fig. 28 Global small intestine market, 2014 - 2025 (USD Million)
Fig. 29 Global another market, 2014 - 2025 (USD Million)
Fig. 30 Neuroendocrine tumor treatment market end-use outlook: Key takeaways
Fig. 31 Neuroendocrine tumor treatment market: End-use movement analysis
Fig. 32 Global hospitals market, 2014 - 2025 (USD Million)
Fig. 33 Global clinics market, 2014 - 2025 (USD Million)
Fig. 34 Global another market, 2014 - 2025 (USD Million)
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Regional outlook, 2014 - 2025 (USD Million)
Fig. 37 North America Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 38 U.S. Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 39 Canada Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 40 Europe Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 41 Germany Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 42 U.K. Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 43 Asia Pacific Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 44 China Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 45 India Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 46 Latin America Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 47 Mexico Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 48 Brazil Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 49 MEA Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)
Fig. 50 South Africa Neuroendocrine tumor treatment market, 2014 - 2025 (USD Million)